Good DD T.G.....,and May I Add BEDA has Basically been Consoladating over 5months..,and has a excellent chance of making it to the 100 & 200MA Very Soon..
I think your BEDA valuation was awesome! Heck, it would have taken me about 10 pages to put what you put into one page.
To add to your valuation, I think there is an "Equity Valuation" that should be considered. Back when BEDA closed the deal to acquire Diagnosis, Inc., they had done so under the consideration of bringing a valuation of $2.5 million into its stock. Considering such and that the acquisition was consummated with 15 million restricted shares, consider below:
$2,500,000 ÷ 15,000,000 Restricted Shares = .167 Per Share
This means that BEDA has a .167 Per Share Equity Valuation for consideration from the Diagnosis, Inc. Acquisition. The news is below that confirmed the acquisition:
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20080121005111&newsLang=en Bederra Corporation completed the acquisition of Diagnos, Inc. in an all-stock transaction. Bederra Corporation issued 15 million restricted common shares of stock for the assets of Diagnosis, Inc.; Diagnos, Inc. will operate as a wholly owned subsidiary of Bederra Corporation. The financial statements issued by the company will reflect the combined financial results. …
…Graham Williams, President of Bederra Corporation, states, “The acquisition of Diagnos, Inc. is the first of many medical related acquisitions planned to enhance our revenues in the coming years.” Projected gross revenues for fiscal year 2008 are anticipated to be in excess of $2.5 million dollars with profits.
News 
Market Data 
Discover 
AI
